Regeneron Pharmaceuticals | REGN - Net Income

Name: Regeneron Pharmaceuticals | REGN - Net Income
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Regeneron,Pharmaceuticals,REGN,Net,Income,stock,equity,live,intraday,earnings,share,price,historical data,chart,calendar,dividend,yield,news

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

Features Questions? Contact us Already a Member? Login

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us

Please Paste this Code in your Website

width

height

Preview

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals reported $817.8M in Net Income for its fiscal quarter ending in March of 2023.

	Net Income		Date
AbbVie ABBV:US	USD 239M	2.23B	Mar/2023
Agenus AGEN:US	USD -68254000	2.84M	Mar/2023
Agios Pharmaceuticals AGIO:US	USD -81018000	117.54M	Mar/2023
Alnylam Pharmaceuticals ALNY:US	USD -174101000	33.39M	Mar/2023
Amgen AMGN:US	USD 2.84B	1.23B	Mar/2023
Astellas Pharma 4503:JP	JPY -46125000000	94.53B	Mar/2023
AstraZeneca AZN:LN	USD 1.8B	902M	Mar/2023
Biogen BIIB:US	USD 387.9M	162.5M	Mar/2023
BioMarin Pharmaceutical BMRN:US	USD 50.85M	51.1M	Mar/2023
Bluebird Bio BLUE:US	USD 21.24M	10.99M	Mar/2023
Bristol-Myers Squibb BMY:US	USD 2.26B	240M	Mar/2023
Eli Lilly LLY:US	USD 1.34B	592.8M	Mar/2023
Esperion Therapeutics ESPR:US	USD -61719000	6.23M	Mar/2023
Gilead Sciences GILD:US	USD 1.01B	630M	Mar/2023
GlaxoSmithKline GSK:LN	GBP 1.49B	5M	Mar/2023
Incyte Corp INCY:US	USD 21.7M	6.76M	Mar/2023
Intercept Pharmaceuticals ICPT:US	USD -32135000	11.31M	Mar/2023
Ionis Pharmaceuticals IONS:US	USD -124323000	71.89M	Mar/2023
Iveric bio Inc. OPHT:US	USD -72229000	13.17M	Mar/2023
J&J JNJ:US	USD -68000000	3.59B	Mar/2023
Kyowa Hakko Kirin 4151:JP	JPY 12.76B	8.4B	Mar/2023
Merck & Co MRK:US	USD 2.82B	196M	Mar/2023
Moderna Inc MRNA:US	USD 79M	1.39B	Mar/2023
Neurocrine Biosciences NBIX:US	USD -76600000	165.6M	Mar/2023
Novartis NOVN:VX	USD 2.29B	827M	Mar/2023
Novartis NVS:US	USD 2.29B	827M	Mar/2023
Pfizer PFE:US	USD 5.54B	548M	Mar/2023
Puma Biotechnology PBYI:US	USD 1.4M	7.01M	Mar/2023
Regeneron Pharmaceuticals REGN:US	USD 817.8M	379.3M	Mar/2023
Roche Holding ROG:VX	3.89B	4.64B	Dec/2022
Sarepta Therapeutics SRPT:US	USD -516755000	407.51M	Mar/2023
Seattle Genetics SGEN:US	USD -174737000	26.57M	Mar/2023
Teva Pharmaceutical Industries Ltd TEVA:IT	USD -206000000	1.02B	Mar/2023
Ultragenyx Pharmaceutical RARE:US	USD -163972000	12.14M	Mar/2023
United Therapeutics UTHR:US	USD 240.9M	108.8M	Mar/2023
Vertex Pharmaceuticals VRTX:US	USD 699.8M	119.1M	Mar/2023